HOME
ABOUT US
TECHNOLOGY
PIPELINES
NEWS
JOIN US
CONTACT
News
CirCode‘s Circular RNA Therapeutic HM2003 Receives FDA Orphan Drug Designation for Thromboangiitis Obliterans
CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world's first circular RNA drug being administrated in patients
CirCode Biomed Just Received First Ever Circular RNA IND Approval from NMPA
Greetings from CirCode at the J.P. Morgan & BIOTECH SHOWCASE annual international conference 2025
HM2002 Injection Completes First Patient Dosing Circular RNA Drug Officially Enters Clinical Trial Stage